Jeffrey Drebin
#59,719
Most Influential Person Now
Researcher
Jeffrey Drebin's AcademicInfluence.com Rankings
Jeffrey Drebinbiology Degrees
Biology
#7568
World Rank
#10510
Historical Rank
Immunology
#903
World Rank
#926
Historical Rank
Jeffrey Drebinphilosophy Degrees
Philosophy
#9587
World Rank
#13169
Historical Rank
Logic
#6558
World Rank
#8086
Historical Rank
Download Badge
Biology Philosophy
Jeffrey Drebin's Degrees
- Doctorate Medicine University of Pennsylvania
- PhD Immunology University of Pennsylvania
Why Is Jeffrey Drebin Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jeffrey Drebin is a surgeon and scientist. He serves as the Department of Surgery Chair at Memorial Sloan Kettering. Biography Drebin earned his MD and Ph.D. from Harvard Medical School, before completing his general surgery residency, and surgical oncology fellowship, at Johns Hopkins Medical School. His Ph.D. research, performed with Mark Greene and Robert Weinberg, involved the creation of monoclonal antibodies targeting the Her2/neu protein and demonstrating in preclinical models that such antibodies could inhibit cancer cell growth in vitro and in vivo. This work was focused on targeted cancer therapy and the creation of the drugs trastuzumab and pertuzumab .
Jeffrey Drebin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1 (2002) (1523)
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells (2013) (1192)
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen (1984) (1139)
- Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy (2014) (776)
- Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET) (2004) (604)
- Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. (2015) (544)
- ErbB receptors: from oncogenes to targeted cancer therapies. (2007) (528)
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies (1985) (414)
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients (2015) (354)
- Radical antegrade modular pancreatosplenectomy. (2003) (267)
- Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. (1986) (232)
- A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage (2014) (230)
- Prospective trial of a blood supply-based technique of pancreaticojejunostomy: effect on anastomotic failure in the Whipple procedure. (2002) (196)
- Survival of Patients Evaluated by FDG-PET Before Hepatic Resection for Metastatic Colorectal Carcinoma: A Prospective Database Study (2001) (192)
- Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. (2014) (189)
- Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial. (2019) (172)
- A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy (2013) (164)
- The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors (2020) (160)
- Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo. (1988) (158)
- Stage- and tissue-specific expression of the neu oncogene in rat development. (1987) (153)
- Utility of Staging Laparoscopy in Subsets of Peripancreatic and Biliary Malignancies (2002) (146)
- Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene (1984) (146)
- Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification (2017) (146)
- Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation (2016) (143)
- The "hidden cystic duct" syndrome and the infundibular technique of laparoscopic cholecystectomy--the danger of the false infundibulum. (2000) (142)
- Evolution and current status of the Whipple procedure: an update for gastroenterologists. (1997) (142)
- Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo. (1988) (138)
- Prevention of breast tumour development in vivo by downregulation of the p185neureceptor (1995) (127)
- National Failure to Operate on Early Stage Pancreatic Cancer (2008) (124)
- Evaluation of 300 Minimally Invasive Liver Resections at a Single Institution: Less Is More (2008) (123)
- Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group (2017) (118)
- Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu. (2000) (112)
- Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. (2014) (110)
- The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. (2009) (109)
- Results of a new strategy for reconstruction of biliary injuries having an isolated right-sided component (2001) (109)
- The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy (2016) (107)
- Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy (2017) (105)
- Early Antibiotic Treatment for Severe Acute Necrotizing Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Study (2008) (99)
- Drain Management after Pancreatoduodenectomy: Reappraisal of a Prospective Randomized Trial Using Risk Stratification. (2015) (94)
- Suppression of β-Catenin Inhibits the Neoplastic Growth of APC-Mutant Colon Cancer Cells (2001) (94)
- A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma. (2013) (93)
- Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy. (2016) (90)
- Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy. (2016) (88)
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. (2019) (86)
- Intraductal Papillary Mucinous Neoplasms: Predictors of Malignant and Invasive Pathology (2008) (85)
- Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score–matched analysis (2016) (85)
- A Risk Model and Cost Analysis of Incisional Hernia After Elective, Abdominal Surgery Based Upon 12,373 Cases (2016) (81)
- Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy (2017) (81)
- Prophylactic octreotide for pancreatoduodenectomy: more harm than good? (2014) (76)
- Survival After Radiofrequency Ablation of Colorectal Liver Metastases: 10-Year Experience (2008) (75)
- Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index. (2015) (73)
- Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. (2018) (70)
- Use of a bipolar vessel-sealing device for parenchymal transection during liver surgery (2002) (67)
- The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas. (2015) (62)
- Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases (2008) (62)
- β-Catenin Antisense Treatment Decreases β-Catenin Expression and Tumor Growth Rate in Colon Carcinoma Xenografts☆ (2001) (58)
- Adjuvant Interferon-based Chemoradiation Followed By Gemcitabine for Resected Pancreatic Adenocarcinoma: A Single-Institution Phase II Study (2008) (56)
- The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN) (2016) (55)
- Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma (2019) (55)
- Prevention of Surgical Resident Attrition by a Novel Selection Strategy (2010) (53)
- Differential binding patterns of monoclonal antibody 2C4 to the ErbB3–p185her2/neu and the EGFR–p185her2/neu complexes (2008) (53)
- Implications of inadequate lymph node staging in resectable gastric cancer: A contemporary analysis using the National Cancer Data Base (2014) (52)
- Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies. (1999) (50)
- Identification of an I-J+ antigen-presenting cell required for third order suppressor cell activation (1983) (50)
- Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program. (2016) (46)
- Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma (2021) (45)
- Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation (2017) (43)
- HER2/neu antisense targeting of human breast carcinoma (2000) (42)
- Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules (2017) (42)
- Genetically restricted antigen presentation for immunological tolerance and suppression (1984) (41)
- Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection. (2019) (41)
- Suppressor T cells and the immune response to tumors. (1984) (40)
- Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease. (2000) (37)
- Assessing the impact of a fistula after a pancreaticoduodenectomy using the Post-operative Morbidity Index. (2013) (37)
- Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. (2001) (37)
- Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells. (2004) (36)
- Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score‐matched analysis of a nationwide clinical oncology database (2017) (36)
- Surgical Palliation for Pancreatic Malignancy: Practice Patterns and Predictors of Morbidity and Mortality (2014) (34)
- Purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel Blue chromatography. (1986) (33)
- Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios (2016) (33)
- Defining the post-operative morbidity index for distal pancreatectomy. (2014) (33)
- CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma (2019) (32)
- 18-Fluorodeoxyglucose Positron Emission Tomography Enhances Computed Tomography Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas (2008) (32)
- Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu. (1998) (31)
- Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. (2020) (31)
- Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis (2016) (31)
- Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations (2018) (31)
- Synergistic antitumor effects of HER2/neu antisense oligodeoxynucleotides and conventional chemotherapeutic agents. (1999) (30)
- Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. (2001) (28)
- Inhibition of tumor growth by monoclonal anti-I-J antibodies. (1983) (27)
- Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen. (1983) (27)
- Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer (2019) (27)
- Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal. (2018) (26)
- Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study. (2016) (25)
- Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis (2017) (24)
- Quantifying the Burden of Complications Following Total Pancreatectomy Using the Postoperative Morbidity Index: A Multi-Institutional Perspective (2014) (24)
- Down-Regulation of HER 2 / neu Expression Induces Apoptosis in Human Cancer Cells That Overexpress HER 2 / neu 1 (2000) (24)
- Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors. (2015) (23)
- Feasibility of electromagnetic transponder use to monitor inter- and intrafractional motion in locally advanced pancreatic cancer patients. (2012) (23)
- Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic ModelAdam R, for the Association Française de Chirurgie (Paul Brousse Hosp, Villejuif, France) Ann Surg 244:524–535, 2006§ (2007) (22)
- Incidence of venous thromboembolism in patients undergoing surgical treatment for malignancy by type of neoplasm: An analysis of ACS-NSQIP data from 2005 to 2010. (2012) (22)
- Pancreatic fistula risk for pancreatoduodenectomy: an international survey of surgeon perception. (2017) (21)
- Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma (2017) (21)
- A Phase II Study of Alternating Cycles of Split Course Radiation Therapy and Gemcitabine Chemotherapy for Inoperable Pancreatic or Biliary Tract Carcinoma (2005) (21)
- Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies (2017) (21)
- Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk). (1995) (20)
- Management of diagnostic dilemmas of the pancreas by ultrasonographically guided laparoscopic biopsy. (1999) (19)
- Targeted Suppression of β-Catenin Blocks Intestinal Adenoma Formation in APC Min Mice (2008) (19)
- Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States (2016) (18)
- Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreatoduodenectomy: Progressive Risk Stratification for Better Practice. (2020) (18)
- Clinical study of genomic drivers in pancreatic ductal adenocarcinoma (2017) (18)
- Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short‐term oncologic outcomes (2015) (18)
- Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal. (2019) (17)
- Analysis of cyst size and tumor markers in the management of pancreatic cysts: support for the original Sendai criteria. (2015) (17)
- Timing of Preoperative Pharmacoprophylaxis for Pancreatic Surgery Patients: A Venous Thromboembolism Reduction Initiative (2011) (17)
- Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model. (2015) (16)
- Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival (2015) (16)
- Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2019) (16)
- Regulation of the immune response to tumor antigens. X. Activation of third-order suppressor T cells that abrogate anti-tumor immune responses. (1984) (16)
- Analysis of hapten-specific T suppressor factors: genetic restriction of TsF1 activity analyzed with synthetic hybrid suppressor molecules. (1984) (15)
- Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer. (2015) (14)
- Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-effectiveness (2006) (14)
- Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer (2013) (14)
- Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. (2019) (13)
- Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment. (2022) (13)
- Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? (2017) (12)
- Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy (2019) (12)
- Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. (2019) (11)
- Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer. (2012) (11)
- Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer (2020) (11)
- A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection. (2019) (11)
- Risk factors for aggressive nonfunctional pancreatic neuroendocrine tumors and the role of endoscopic ultrasound guided fine-needle aspiration (2016) (11)
- PRELIMINARY EVIDENCE OF AN ASSOCIATION BETWEEN AN ACTIVATED CELLULAR TRANSFORMING GENE AND A TUMOR-SPECIFIC TRANSPLANTATION ANTIGEN11This work was supported by grants from the NIH. (1982) (11)
- Pancreaticoduodenectomy for Lymphoepithelial Cyst of the Pancreas (2000) (10)
- Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy (2020) (10)
- Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. (2019) (10)
- Intraoperative Molecular Imaging: The Surgical Oncologist's North Star. (2017) (10)
- Long-term Follow-up of a Randomized Trial Comparing the Beger and Frey Procedures for Patients Suffering From Chronic Pancreatitis (2006) (10)
- Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis. (2022) (9)
- Treatment patterns and survival in patients with early‐onset pancreatic cancer (2021) (9)
- Taking the Initiative: Risk-Reduction Strategies and Decreased Malpractice Costs. (2017) (9)
- Local Control and Survival After Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma With Vascular Involvement (2021) (8)
- Cancer Surgery and COVID19 (2020) (8)
- Preoperative Evaluation of Pancreatic Cystic Lesions: Cost-Benefit Analysis and Proposed Management AlgorithmLim SJ, Alasadi R, Wayne JD, et al (Northwestern Univ, Chicago) Surgery 138:672–680, 2005§ (2006) (8)
- Is minimally invasive surgery of lesions in the right superior segments of the liver justified? A multi‐institutional study of 245 patients (2020) (8)
- Identification of p185neu sequences required for monoclonal antibody- or ligand-mediated receptor signal attenuation. (1997) (8)
- An Aggressive Surgical Approach Leads to Improved Survival in Patients With Gallbladder Cancer: A 12-Year Study at a North American Center (2006) (7)
- A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer (2018) (7)
- Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms (2020) (7)
- Suppression of β-Catenin by Antisense Oligomers Augments Tumor Response to Isolated Limb Perfusion in a Rodent Model of Adenomatous Polyposis Coli–Mutant Colon Cancer (2005) (7)
- Differential antigen presentation in tumor immunity. (1984) (7)
- Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy (2020) (7)
- Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (7)
- Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review. (2021) (7)
- Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185neu. (1991) (7)
- Regulation of the immune response to antigens on the malignant cell surface (2004) (7)
- Laparoscopic Distal Pancreatectomy: Results on a Consecutive Series of 58 Patients (2008) (6)
- Successful venous repair and reconstruction for oncologic resections. (2016) (6)
- The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. (2021) (6)
- Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy (2020) (6)
- A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC). (2018) (6)
- Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy. (2020) (5)
- Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases (2019) (5)
- Extrahepatic Cholangiocarcinoma Developing in the Setting of AIDS Cholangiopathy (2013) (5)
- Development of monoclonal antibodies reactive with the product of the neu oncogene. (1986) (4)
- Timing of Complication and Failure to Rescue after Hepatectomy: Single-Institution Analysis of 28-Years of Hepatic Surgery. (2021) (4)
- Operative indications for relatively small (2–5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated casesOtani Y, Furukawa T, Yoshida M, et al (Keio Univ, Japan; Natl Tokyo Med Ctr) Surgery 139:484–492, 2006§ (2007) (4)
- Vitamin D receptor agonist paricalcitol plus gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer. (2020) (4)
- Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care (2021) (4)
- Recombinant DNA Technology (1991) (4)
- Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery (2020) (3)
- Doxycycline and indomethacin synergistically downregulate beta-catenin signaling and inhibit colon cancer cell growth (2003) (3)
- Aggressive Supportive Care Improves Outcomes in the Combined Modality Treatment of Pancreatic and Duodenal Cancer (2007) (3)
- Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? (2020) (3)
- Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2020) (3)
- A Selective Approach to the Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive PatientsAllen PJ, D'Angelica M, Gonen M, et al (Mem Sloan-Kettering Cancer Ctr) Ann Surg 244:572–582, 2006§ (2007) (3)
- Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver‐related mortality (2020) (3)
- Comprar The Surgical Review, 4th Ed. An Integrated Basic And Clinical Science Study Guide | Paige M. Porrett | 9781451193329 | Lippincott Williams & Wilkins (2015) (3)
- Lending a hand for laparoscopic distal pancreatectomy: the optimal approach? (2019) (3)
- Abstract 619: Identification of clinically actionable genomic alterations in the tumor and circulation of pancreatic cancer patients (2015) (3)
- Abstract CT085: Randomized phase II trial of hydroxychloroquine in combination with gemcitabine/nab-paclitaxel to inhibit autophagy in pancreatic cancer: A SU2C-funded trial (2018) (3)
- Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy (2022) (3)
- Defining postoperative weight change after pancreatectomy: Factors associated with distinct and dynamic weight trajectories. (2020) (3)
- Neoadjuvant nab-paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX. (2016) (3)
- Toxicity study of gemcitabine, oxaliplatin, and bevacizumab followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy in patients with locally advanced pancreatic cancer. (2012) (3)
- A contemporary analysis of palliative procedures in aborted pancreatoduodenectomy: Morbidity, mortality, and impact on future therapy. (2020) (3)
- 487 Fistula Risk Assessment for Pancreatoduodenectomy: A Call for Consensus (2015) (2)
- Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma. (2022) (2)
- Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival (2021) (2)
- Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas (2021) (2)
- Invasive central venous monitoring during hepatic resection: unnecessary for most patients. (2019) (2)
- Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implications for Re-resection (2008) (2)
- A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma (2007) (2)
- Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal CancerLevine EA, Farmer MR, Clark P, et al (Wake Forest Univ, Winston-Salem, NC) Ann Surg 243:472–478, (2007) (2)
- The role of antigen-presenting cells in regulating the immune response to tumor antigens. (1984) (2)
- Techniques for Biliary and Pancreatic Reconstruction After Pancreaticoduodenectomy (2002) (2)
- 784 A Multi-Institutional External Validation of the Fistula Risk Score for Pancreaticoduodenectomy (2013) (2)
- The Role of the Calypso System in Monitoring Interfraction Motion in the Definitive Treatment of Unresectable Pancreatic Cancer (2010) (2)
- Targeted transgastric drainage of isolated pancreatic duct segments to cure persistent pancreaticocutaneous fistulas from pancreatitis. (2015) (2)
- Intraoperative Near-Infrared Imaging with Second Window Indocyanine Green for Pancreatic Adenocarcinoma (2017) (2)
- Carcinoma of the Pancreas (2008) (2)
- Tumors of the Biliary Tract (2009) (2)
- Resection of Pancreatic Neuroendocrine Tumors: Results of 70 Cases (2007) (1)
- Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma. (2022) (1)
- Growth inhibitory effects of indomethacin on human colon cancer cells are mediated, in-part, by effects on beta-catenin (2008) (1)
- REGULATION OF THE IMMUNE RESPONSE TO CELL SURFACE ANTIGENS (1982) (1)
- Abstract 2444: The use of CT radiomics to predict immune infiltrate in pancreatic ductal adenocarcinoma (2019) (1)
- Targeted Therapy of Cancer (2016) (1)
- Association of genomic profiles and survival in early onset and screening‐age colorectal cancer patients with liver metastases resected over 15 years (2022) (1)
- Postoperative ERCP Versus Laparoscopic Choledochotomy for Clearance of Selected Bile Duct Calculi: A Randomized TrialNathanson LK, O'Rourke NA, Martin IJ, et al (Royal Brisbane Hosp, Australia; Princess Alexandria Hosp, Brisbane, Australia) Ann Surg 242:188–192, 2005.§ (2006) (1)
- Concurrent Nab-paclitaxel and Radiotherapy (2021) (1)
- Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia (2019) (1)
- Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity. (2020) (1)
- Segmental vs. Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection. (2022) (1)
- Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients (2020) (1)
- 863 The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy (2015) (1)
- Pancreatic cystic neoplasms: why not operate? (2009) (1)
- Enhanced PAtient Clinical Streamlining (EPACS): Quality Initiative to Improve Healthcare for New Surgical Outpatient Visits (2022) (1)
- Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses (2022) (1)
- Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases (2020) (1)
- 459 The Value of Drains as a Fistula Mitigation Strategy for Pancreatoduodenectomy: Something for Everyone? Results of a Randomized Prospective Multi-Institutional Study (2014) (1)
- Survival in Patients with Intrahepatic Cholangiocarcinoma and Positive Lymph Nodes: No Benefit of Resection over Hepatic Arterial Infusion Chemotherapy (2020) (1)
- Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma (2021) (1)
- Decoding grade B pancreatic fistula: a clinical and economical analysis and sub-classification proposal (2018) (1)
- Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma (2021) (1)
- Hepatocellular carcinoma in patients with no identifiable risk factors. (2019) (1)
- Change in circulating tumor DNA after hepatic resection for metastatic colorectal cancer (2018) (1)
- A combined radiomics and cyst fluid inflammatory markers model to predict preoperative risk in pancreatic cystic lesions (2020) (1)
- Trastuzumab in breast cancer. (2006) (1)
- Number and percentage of pathologically involved lymph nodes (pLN) in patients (pts) with pancreatic adenocarcinoma (PA) predicts for overall survival (OS) in pts treated with postoperative adjuvant chemoradiotherapy (CRT) (2008) (0)
- QS112. Non-Steroidal Anti-Inflammatory Drugs Inhibit Beta-Catenin in Human Colon Cancer Cells Via Effects on mRNA Expression (2008) (0)
- Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship (2019) (0)
- Repeat cholecystectomy for the retained gallbladder remnant: presentation and management (2018) (0)
- Aggressive surgical resection for pancreatic neuroendocrine tumors (2016) (0)
- Monoclonal Antibodies Reactive with the neu Oncogene Product Inhibit the Neoplastic Properties of neu-Transformed Cells (1987) (0)
- Central Pancreatectomy Revisited (2007) (0)
- Prostaglandin mediated radioprotection of colon cancer occurs by inhibition of the RNA binding protein CUGBP2 (2003) (0)
- ASO Visual Abstract: Enhanced PAtient Clinical Streamlining (EPACS)—Quality Initiative to Improve Healthcare for New Surgical Outpatient Visits (2022) (0)
- 5 Featured Laboratory (2008) (0)
- Long-term survival and quality of life after total pancreatectomy (2005) (0)
- Early and Late Complications After Pancreatic Necrosectomy (2006) (0)
- CT radiomics to predict early hepatic recurrence after resection for intrahepatic cholangiocarcinoma (2022) (0)
- The Optical Biopsy: A Novel Technique for Rapid Intraoperative onary Adenocarcinomas Diagnosis of Primary Pulm (2015) (0)
- Analysis of the neu-Encoded Protein and Its Mechanism of Oncogenic Activation (1986) (0)
- Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. (2023) (0)
- Regional differences in gallbladder cancer pathogenesis: Insights from a comparison of tumor mutations (2018) (0)
- Reducing Complications and Improving Outcomes in Pancreas Surgery (2015) (0)
- Laparoscopic Pancreaticoduodenectomy: Technique and Outcomes (2008) (0)
- Challenges in Laparoscopic GI Surgery (2015) (0)
- An Aggressive Surgical Approach Leads to Long-term Survival in Patients With Pancreatic Endocrine TumorsFendrich V, Langer P, Celik I, et al (Philipps-Univ Marburg, Germany; Städtische Kliniken Bielefeld-Mitte, Bielefeld, Germany) Ann Surg 244:845–853, 2006§ (2007) (0)
- Long-term Outcomes of Laparoscopic Resection of Gastric Gastrointestinal Stromal Tumors (2007) (0)
- Corralling Pancreatic Cancer through Epigenetic Reprogramming (2018) (0)
- Translational Cancer Research: The Surgeon's Role (2017) (0)
- Mono clonal antibodies reactive with a 185 kilodalton phospho protein associated with the transforming genes of several rat neuro blastomas (1984) (0)
- Surgical Treatment of Pancreatic Head Carcinoma in Elderly Patients (2007) (0)
- Alterations in Driver Genes Are Associated with Response to Neoadjuvant Folfirinox in Patients with Nonmetastatic Pancreatic Ductal Adenocarcinoma (2021) (0)
- Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing. (2023) (0)
- Serous Cystadenoma of the Pancreas: Tumor Growth Rates and Recommendations for TreatmentTseng JF, Warshaw AL, Sahani DV, et al (Massachusetts Gen Hosp, Boston) Ann Surg 242:413–421, 2005§ (2006) (0)
- Su1834 A National Perspective of Invasive Intraductal Papillary Mucinous Neoplasm (IPMN) (2014) (0)
- 37 – Cancer Genetics (2001) (0)
- Improved mortality after pancreatectomy in the modern era (2018) (0)
- Is Detection of Asymptomatic Recurrence After Curative Resection Associated With Improved Survival in Patients With Gastric Cancer?Bennett JJ, Gonen M, D'Angelica M, et al (Memorial Sloan-Kettering Cancer Ctr, New York) J Am Coll Surg 201:503–510, 2005§ (2006) (0)
- Selection Criteria for Simultaneous Resection in Patients With Synchronous Liver MetastasisMinagawa M, Yamamoto J, Miwa S, et al (Univ of Tokyo; Cancer Inst Hosp, Tokyo; Natl Cancer Ctr, Tokyo; et al) Arch Surg 141:1006–1012, 2006§ (2007) (0)
- Diagnosis of Venous Thromboembolism as an Outpatient in Patients Undergoing Surgical Treatment for Malignancy: An Analysis of ACS NSQIP Data 2005-2008 (2012) (0)
- Evaluation of the Implementation of Enhanced Recovery after Surgery Pathways in Pancreatic Surgery (2022) (0)
- Activation of suppressor cells is genetically restricted by the I-J Subregion (1983) (0)
- Survival following partial pancreatectomy and radiation for ampullary adenocarcinoma (2008) (0)
- Survival following resection of pancreatic cancers may not be affected by length of hospital stay or delay to initiating adjuvant chemoradiation (CRT) (2008) (0)
- A Prospective Cohort Study of a Perioperative Bundle to Reduce Surgical Site Infection following Pancreaticoduodenectomy (2021) (0)
- Erratum: Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (26835–26845) DOI: 10.1073/pnas.1914915116) (2020) (0)
- Patterns of recurrence and peri-operative predictors of liver metastasis after pancreatic cancer resection (2018) (0)
- Evidence-Based Treatment of Acute Pancreatitis: A Look at Established Paradigms (2007) (0)
- Pathology remains the most important predictor of long-term survival using a modern prognostic nomogram for resected pancreatic ductal adenocarcinoma (2019) (0)
- Quality-of-Life After Total Pancreatectomy: Is It Really That Bad on Long-term Follow-up? (2006) (0)
- Analysis of Cyst Size and Tumor Markers: In reply to Goh. (2015) (0)
- Preoperative Positron Emission Tomography to Evaluate Potentially Resectable Hepatic Colorectal MetastasesJoyce DL, Wahl RL, Patel PV, et al (Johns Hopkins Med Insts, Baltimore, Md) Arch Surg 141:1220–1226, 2006§ (2007) (0)
- Pancreaticoduodenectomy Is Curative in the Majority of Patients With Node-Negative Ampullary CancerBrown KM, Tompkins AJ, Yong S, et al (Loyola Univ Med Ctr, Maywood, III) Arch Surg 140:529–533, 2005§ (2006) (0)
- Incidence of Venous Thromboembolism in Patients Undergoing Surgical Treatment for Malignancy: An Analysis of ACS NSQIP Data 2005-2008 (2012) (0)
- Open Distal Pancreatectomy (2017) (0)
- Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome. (2023) (0)
- Results of a new strategy for reconstruction of biliary injuries having an isolated right sided component (2000) (0)
- HER2/neu Antisense Therapeutics in Human Breast Cancer (2002) (0)
- CHAPTER 14 – Pancreatic Resection (2009) (0)
- Resected Pancreatic Cancer with Favorable Prognosis: is Adjuvant Therapy Beneficial? (2013) (0)
- Outcomes following transarterial embolization for hepatocellular carcinoma with complete radiologic response (2018) (0)
- Rates and Treatment Patterns of Gallbladder-Related Emergency General Surgery Conditions in the Cancer Population (2022) (0)
- Differentiation of mucinous cysts and simple cysts of the liver using preoperative imaging (2022) (0)
- Outcome after Pancreaticoduodenectomy for Cancer in Elderly PatientsScurtu R, Bachellier P, Oussoultzoglou E, et al (Hôpitaux Universitaires de Strasbourg, CHU Hautepierre, France) J Gastrointest Surg 10:813–822, 2006§ (2007) (0)
- Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. (2022) (0)
- Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen ( immunotherapy / neu oncogene ) (0)
- A retrospective study of hepatic arterial infusion (HAI) FUDR/Dex and mitomycin C (MMC) for chemotherapy refractory unresectable intrahepatic cholangiocarcinomas (ICC). (2019) (0)
- Timing of Complications and Failure to Rescue after Hepatectomy: A Single-Institution Analysis of 28 Years of Hepatic Operations (2020) (0)
- Comparing the Burden of Fistulas for Proximal and Distal Pancreatic Resections Using the Postoperative Morbidity Index (2014) (0)
- External stents for pancreatoduodenectomy provide value only in high risk scenarios (2016) (0)
- Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage. (2023) (0)
- Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO). (2023) (0)
- Su1547 Failure to Receive Adjuvant Therapy Following Resection for Pancreatic Cancer: Patterns and Implications (2012) (0)
- Abstract 798: Clonal analysis and clinical translation of pancreatic adenocarcinoma genomes. (2013) (0)
- Medical and Surgical Therapy of Pancreatic Cancer (2006) (0)
- HER2/neu overexpression interferes with retinoblastoma protein-mediated cell cycle regulation in human pancreatic carcinoma cells (1998) (0)
- Predictors of Mortality in Patients Undergoing Palliative Bypass for Pancreatic Malignancy (2014) (0)
- Defining Postoperative Weight Change Following Pancreatectomy: Factors Associated With Distinct And Dynamic Weight Trajectories (2020) (0)
- Alternating cycles of full dose split course radiation therapy and gemcitabine chemotherapy for unresectable pancreatic carcinoma (2002) (0)
- Abstract PR7: Clonal profiling of prospectively collected primary pancreatic ductal adenocarcinomas. (2012) (0)
- Liver Transplantation With Neoadjuvant Chemoradiation Is More Effective Than Resection for Hilar CholangiocarcinomaRea DJ, Heimbach JK, Rosen CB, et al (Mayo Clinic, Rochester, Minn) Ann Surg 242:451–461, 2005§ (2006) (0)
- Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal cancer hepatic metastases (CRLM). (2019) (0)
- Non-alcoholic fatty liver disease is an independent predictor of recurrence after resection of colorectal liver metastases (2019) (0)
- The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous Neoplasms. (2023) (0)
- ASO Visual Abstract: Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial embolization: A Retrospective Study on Patterns, Treatments, and Prognosis (2022) (0)
- Paradoxical effect of proteasome inhibition on beta-catenin expression in APC-mutant and beta-catenin mutant human colon cancer cells (2005) (0)
- ASO Visual Abstract: A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases (2023) (0)
- Resection of colorectal liver metastases after early failure of adjuvant systemic chemotherapy for the primary tumor: Is there a role for additional treatment (2018) (0)
- ASO Visual Abstract: Recurrence After Resection of Pancreatic Cancer – Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (0)
- Comment on Hasselgren K, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448. (2021) (0)
- Phase II trial of maximal ablative irradiation because of encasement (MAIBE) for patients with potentially resectable locally advanced pancreatic cancer. (2023) (0)
- Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. (2023) (0)
- Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up (2007) (0)
- Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous Neoplasms (2023) (0)
- Generation of an Actionable, Preoperative Risk Prediction and Cost Model for Incisional Hernia Using Longitudinal Multi-Hospital Health Data (2017) (0)
This paper list is powered by the following services:
Other Resources About Jeffrey Drebin
What Schools Are Affiliated With Jeffrey Drebin?
Jeffrey Drebin is affiliated with the following schools:
